En Es
Categories

Industry News

Danaher Acquires Integrated DNA Technologies

By Labmedica International staff writers
13 Mar 2018

Image: Danaher Corporation has entered into a definitive agreement to acquire Integrated DNA Technologies (Photo courtesy of iStock).Danaher Corporation (Washington, D.C, USA) has entered into a definitive agreement to acquire Integrated DNA Technologies (IDT) (Skokie, IL, USA), a privately held provider of high-value consumables for genomics applications in molecular biology, qPCR, next generation sequencing, synthetic biology, gene editing and molecular diagnostics.

IDT develops, manufactures, and markets nucleic acid products for the life sciences industry in the areas of academic research, biotechnology, agriculture, medical diagnostics, and pharmaceutical development. The company's primary business is the production of custom oligonucleotides for molecular biology applications. IDT has developed proprietary technologies for genomics applications such as next generation sequencing, CRISPR genome editing, qPCR, and RNA interference. Through its GMP services, IDT manufactures products used in diagnostic tests for many forms of cancer and most inherited and infectious diseases. IDT will operate as a standalone operating company and brand within Danaher's Life Sciences platform.

"We are thrilled to have IDT join Danaher's Life Sciences platform," said Rainer Blair, Executive Vice President of Danaher's Life Sciences platform. "IDT expands our presence into the highly attractive genomics market and will help play a central role in accelerating our customers' research and time to market as they develop critical diagnostic tests and potential life-saving therapies. IDT's historical double-digit core revenue growth and strong margins are a testament to the team's commitment to the highest standards of quality, service, and technical expertise."

"Danaher is a proven steward of founder-led businesses, such as Hach and Phenomenex. We recognize the extraordinary contributions Dr. Walder and IDT have made to the advancement of genomics research and applications over the past 30 years," said Thomas P. Joyce, Jr., Danaher President and Chief Executive Officer. "We look forward to supporting the IDT team and helping them leverage the tools of the Danaher Business System (DBS) to further enhance their growth profile and continue to create long-term customer value."

"For more than 30 years, IDT's innovative tools and solutions for genomics applications have helped scientists advance their research and contribute to solving some of the world's most vexing diseases and other challenges addressed by the life sciences community," added Joseph Walder, CEO and Chairman of IDT. "Joining Danaher will allow us to accelerate the high pace of innovation and superior service our customers have come to expect from us, as well as help expand our global reach. I'm excited to watch IDT further grow and innovate in this expanding area of genomics with the help of DBS."



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

12 Jun 2018
AI Software Platform Aims to Synthesize Biomedical Knowledge
nference, which focuses on artificial intelligence (AI)-powered life sciences, is developing an AI software platform to synthesize the exponentially growing biomedical knowledge.
Read More
11 Jun 2018
MEDICA 2018 Launches App Competition for Smart Products
The search for the best health app solutions in the world has begun with the launch of the seventh MEDICA App Competition. The competition is meant for applications for smart phones, smart watches, tablets or AR/VR glasses, but excludes fitness or wellness applications. All submitted applications for the MEDICA App Competition 2018 must have a connection with professional medical technology, and applications from start-ups that are still in the early stage are also invited.
Read More
07 Jun 2018
New AI Algorithm Makes Liver Cancer Surgery Safer
Researchers at the Fraunhofer Institute for Medical Image Computing MEVIS have developed algorithms that analyze patients’ imaging data and calculate surgical risks, making liver cancer surgery safer and easier to plan. Researchers at Fraunhofer have been working on image-processing algorithms for use in medicine since 1998. The method is now widely known among physicians as MEVIS analysis and has become established in practice.
Read More
07 Jun 2018
AI-based Interpretation Tool Receives CE Certification
qXR, an AI-based chest X-ray interpretation tool that detects 15 of the most common chest X-ray abnormalities with an accuracy of more than 90%, has received CE certification. Developed by healthcare AI start-up Qure.ai, qXR has been trained on more than one million chest X-rays and uses a heat map or bounding box to point out abnormalities to the clinician, aiding rapid con?rmation in just milliseconds.
Read More
07 Jun 2018
Global Radiation Detection Market to Reach USD 2 Billion by 2022
The global radiation detection, monitoring, and safety market is expected to grow at a CAGR of 5.7% from USD 1.71 billion in 2017 to USD 2.26 billion by 2022. The market is likely to be driven by rising security threats, increasing prevalence of cancer across the world, growing safety awareness among people working in radiation-prone environments, rising safety concerns following the Fukushima disaster, expanding security budgets of global sporting events, increase in the number of PET/CT scans, growing usage of nuclear medicine and radiation therapy for diagnosis and treatment, and use of drones for radiation monitoring. However, nuclear energy alternatives such as renewable energy, nuclear power phase-out, and shortage of nuclear power workforce, are likely to limit the market growth.
Read More
06 Jun 2018
Siemens Healthineers and ScreenPoint Medical to Develop AI-Based Apps
Siemens Healthineers and ScreenPoint Medical have entered into a partnership to develop artificial intelligence (AI)-based applications for breast imaging. As part of the arrangement, Siemens Healthineers will also acquire a strategic minority stake in ScreenPoint Medical.
Read More
06 Jun 2018
Qure.ai Partners with Teleradiology Solutions for Smarter Diagnoses
Healthcare artificial intelligence (AI) provider, Qure.ai has partnered with Teleradiology Solutions and Telerad Tech to enable smarter and faster diagnoses of X-ray and CT scan data, and reduce costs.
Read More
06 Jun 2018
Algorithms to Enhance Approach for Detecting Tumors
Case Western Reserve University has entered into a collaboration with the Quantum team at Microsoft to use the power of quantum computing for improving patient care. CWRU will use Microsoft’s quantum-inspired algorithms to enhance their approach to detecting cancerous tumors.
Read More
31 May 2018
CerTest Biotec Opens New Facility for Diagnostic Products
CerTest Biotec, a biotechnology company focused on the development and manufacturing of IVD diagnostic products, has opened a new facility in Spain for the research, development and manufacture of molecular diagnostics products.
Read More
Copyright © 2000-2018 TradeMed.com. All rights reserved. | Terms And Conditions